CPHL results Citi Pharma Ltd.
Citi Pharma Ltd. (CPHL) has 10 results with figures on file. Quarter ended 30 Sep 2026: earnings per share Rs 1.02, sales Rs 3.4 bn, up 14.6% on the same quarter a year before. The next results are expected between 13 Feb 2027 and 15 Mar 2027 (a projection, not an announced date).
One line for each result
- Quarter ended 30 Sep 2026: earnings per share Rs 1.02, sales Rs 3.4 bn, up 14.6% on the same quarter a year before.
- Year ended 30 Jun 2026: earnings per share Rs 3.43, sales Rs 14.0 bn, down 12.1% on the year before.
- Quarter ended 31 Mar 2026: earnings per share Rs 1.21, sales Rs 3.1 bn, up 26.0% on the same quarter a year before.
- Quarter ended 31 Dec 2025: earnings per share Rs 1.77, sales Rs 4.3 bn.
- Quarter ended 30 Sep 2025: earnings per share Rs 0.89, sales Rs 3.4 bn.
- Year ended 30 Jun 2025: earnings per share Rs 3.90, sales Rs 13.2 bn, up 6.8% on the year before.
- Quarter ended 31 Mar 2025: earnings per share Rs 0.96, sales Rs 3.3 bn.
- Year ended 30 Jun 2024: earnings per share Rs 3.65, sales Rs 12.4 bn, up 26.7% on the year before.
- Year ended 30 Jun 2023: earnings per share Rs 2.88, sales Rs 12.4 bn, unchanged on the year before.
- Year ended 30 Jun 2022: earnings per share Rs 2.88, sales Rs 9.8 bn.
Written from the figures below. Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later.
When the next results are due
Next results
Half-year results, to 31 Dec 2026: expected between 13 Feb 2027 and 15 Mar 2027.
A projection, not an announced date. An estimate from the dates of the last 5 filings.
Results dates on record
| Date | What | Status |
|---|---|---|
| 13 Feb 2027 | Half-year results expected between 13 Feb 2027 and 15 Mar 2027 | Expected window, not an announced date |
| 2 Nov 2026 | Quarterly results, to 30 Sep 2026 | Filed with the exchange |
Source: the exchange’s results announcements. An expected window is an estimate from the dates of earlier filings.
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 1.02 | Rs 3.4 bn | Rs 233.2 m | 6.9% | +14.6% |
| Quarter to 31 Mar 2026 | 1.21 | Rs 3.1 bn | Rs 275.4 m | 8.9% | +26.0% |
| Quarter to 31 Dec 2025 | 1.77 | Rs 4.3 bn | Rs 404.3 m | 9.3% | — |
| Quarter to 30 Sep 2025 | 0.89 | Rs 3.4 bn | Rs 203.7 m | 6.0% | — |
| Quarter to 31 Mar 2025 | 0.96 | Rs 3.3 bn | Rs 220.4 m | 6.6% | — |
Results filings at the exchange
| Date | Filing | Kind | |
|---|---|---|---|
| 2 Nov 2026 | Transmission of Quarterly Report for the Period Ended 30 September 2026 | Quarterly accounts | |
| 2 Nov 2026 | Financial Results for the Quarter Ended 30 September 2026 | Quarterly accounts | |
| 5 Oct 2026 | Financial Results for the Year Ended 30 June 2026 | Financial results | |
| 30 Apr 2026 | Financial Results for the Quarter Ended 31 March 2026 | Quarterly accounts | |
| 31 Mar 2026 | Quarterly report 2026 | Quarterly accounts | |
| 13 Feb 2026 | Financial Results for the Quarter Ended December 31, 2025 | Quarterly accounts | |
| 31 Dec 2025 | Quarterly report 2025 | Quarterly accounts | |
| 30 Sep 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Mar 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Dec 2024 | Quarterly report 2024 | Quarterly accounts | |
| 30 Sep 2024 | Quarterly report 2024 | Quarterly accounts | |
| 31 Mar 2024 | Quarterly report 2024 | Quarterly accounts | |
| 31 Dec 2023 | Quarterly report 2023 | Quarterly accounts | |
| 30 Sep 2023 | Quarterly report 2023 | Quarterly accounts | |
| 31 Mar 2023 | Quarterly report 2023 | Quarterly accounts | |
| 31 Dec 2022 | Quarterly report 2022 | Quarterly accounts | |
| 30 Sep 2022 | Quarterly report 2022 | Quarterly accounts | |
| 31 Mar 2022 | Quarterly report 2022 | Quarterly accounts | |
| 31 Dec 2021 | Quarterly report 2021 | Quarterly accounts | |
| 30 Sep 2021 | Quarterly report 2021 | Quarterly accounts | |
| — | Quarterly September | Quarterly accounts | |
| — | Quarterly September | Quarterly accounts | |
| — | Quarterly September | Quarterly accounts | |
| — | Quarterly March | Quarterly accounts | |
| — | Quarterly December | Quarterly accounts | |
| — | Quarterly September | Quarterly accounts | |
| — | Quarterly December | Quarterly accounts | |
| — | Quarterly March | Quarterly accounts | |
| — | Quarterly September | Quarterly accounts | |
| — | Quarterly March | Quarterly accounts | |
| — | Quarterly March | Quarterly accounts | |
| — | Quarterly December | Quarterly accounts | |
| — | Quarterly September | Quarterly accounts | |
| — | Quarterly December | Quarterly accounts | |
| — | Quarterly December | Quarterly accounts |
35 filings stored.
More on CPHL
- CPHL share price and overview
- CPHL dividend history
- Pharmaceuticals sector
- CWHC results · Crestwell Healthcare Limited
- FEROZ results · Ferozsons Laboratories Limited
- GLAXO results · GlaxoSmithKline Pakistan Limited
- ABOT results · Abbott Laboratories (Pakistan) Limited
- HALEON results · Haleon Pakistan Limited
- HINOON results · Highnoon Laboratories Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .